Abstract:Background--Vascular diseases are the principal causes of death and disability in people with diabetes. At the same time, studies suggest a protective role of diabetes in the development of abdominal aortic aneurysms. We sought to determine whether diabetes is associated with decreased hospitalization due to thoracic aortic aneurysms and dissections (TAAD).
“…The other known TAD risk factors included in the model as potential confounders were age; sex; hypertension; heritable connective tissue disease (Marfan syndrome, Ehlers-Danlos syndrome, and osteogenesis imperfecta); Turner syndrome; inflammation of the aorta (giant cell arteritis, Takayasu arteritis, systemic lupus erythematosus, polyarteritis nodosa, granulomatosis with polyangiitis, and cardiovascular syphilis); blunt trauma; pregnancy; cocaine use; amphetamine use; atherosclerosis; lipid disorders; and diabetes [1,24,[27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43]. There is no ICD-9 code for Loeys-Dietz syndrome, so it could not be evaluated.…”
“…The other known TAD risk factors included in the model as potential confounders were age; sex; hypertension; heritable connective tissue disease (Marfan syndrome, Ehlers-Danlos syndrome, and osteogenesis imperfecta); Turner syndrome; inflammation of the aorta (giant cell arteritis, Takayasu arteritis, systemic lupus erythematosus, polyarteritis nodosa, granulomatosis with polyangiitis, and cardiovascular syphilis); blunt trauma; pregnancy; cocaine use; amphetamine use; atherosclerosis; lipid disorders; and diabetes [1,24,[27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43]. There is no ICD-9 code for Loeys-Dietz syndrome, so it could not be evaluated.…”
“…7,8 However, although vascular complications remain as the principal causes of death and disability in diabetes mellitus, epidemiological evidence suggests an inverse association between diabetes mellitus and aortic aneurysms and dissections. 9,10 These findings demonstrate the multiple facets of diabetes mellitus on the vasculature, and a more holistic approach might advance our insights in the vascular risk associated with diabetes mellitus at a molecular level. 11 In this issue of the journal, Husi et al 12 report the results of a proteomics analysis of the diabetic mouse aorta.…”
“…Increased smooth muscle tone is known to increase damping of high‐frequency energy content, which raises concerns that too much of a decrease in stress and stiffness could promote thoracic aortic aneurysm. An inverse relationship between higher vessel wall stiffness and lower risk for aneurysm has been reported56 in patients with diabetes mellitus, where there is a decreased incidence of thoracic aortic aneurysms and dissection, which is thought to be due to protective cross‐linking of structural proteins. Additional study may be warranted to test the hypothesis that excessive reduction in aortic stiffness could have the negative side effect of increasing risk for aneurysm development.…”
BackgroundThe proximal aorta normally functions as a critical shock absorber that protects small downstream vessels from damage by pressure and flow pulsatility generated by the heart during systole. This shock absorber function is impaired with age because of aortic stiffening.Methods and ResultsWe examined the contribution of common genetic variation to aortic stiffness in humans by interrogating results from the AortaGen Consortium genome‐wide association study of carotid‐femoral pulse wave velocity. Common genetic variation in the N‐WASP (WASL) locus is associated with carotid‐femoral pulse wave velocity (rs600420, P=0.0051). Thus, we tested the hypothesis that decoy proteins designed to disrupt the interaction of cytoskeletal proteins such as N‐WASP with its binding partners in the vascular smooth muscle cytoskeleton could decrease ex vivo stiffness of aortas from a mouse model of aging. A synthetic decoy peptide construct of N‐WASP significantly reduced activated stiffness in ex vivo aortas of aged mice. Two other cytoskeletal constructs targeted to VASP and talin‐vinculin interfaces similarly decreased aging‐induced ex vivo active stiffness by on‐target specific actions. Furthermore, packaging these decoy peptides into microbubbles enables the peptides to be ultrasound‐targeted to the wall of the proximal aorta to attenuate ex vivo active stiffness.ConclusionsWe conclude that decoy peptides targeted to vascular smooth muscle cytoskeletal protein‐protein interfaces and microbubble packaged can decrease aortic stiffness ex vivo. Our results provide proof of concept at the ex vivo level that decoy peptides targeted to cytoskeletal protein‐protein interfaces may lead to substantive dynamic modulation of aortic stiffness.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.